For holders of American Depositary Receipts (ADRs) of Novartis AG

Notice of Annual General Meeting

The Novartis 2025 Annual General Meeting took place on March 07, 2025 in Basel, Switzerland.

Notice of Annual General Meeting (PDF 0.6 MB)

Brochure "Compensation Votes at the 2025 Annual General Meeting" (PDF 0.1 MB)
 

Novartis Annual Report 2024 cover: Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Reporting and transparency hub

The Novartis Annual Report 2024 and US Securities & Exchange Commission Form 20-F 2024 provide a comprehensive overview of Novartis, including our company structure, corporate governance, operating and financial results, and compensation practices. They are filed with the SIX Swiss Exchange in Switzerland and the Securities and Exchange Commission in the US.

Visit the Novartis Reporting and Transparency Hub

Order the Annual Report 2024 or the Notice of Annual General Meeting(link is external)

Find further information on our Corporate Governance
 

ADR voting

If you obtained your ADRs through an Employee Plan or you hold ADRs directly registered with the depositary, please visit the voting site and follow the directions provided.

If you hold ADRs beneficially through a broker, you must follow the instructions and use a voting card and the process provided by your broker.